Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Harm van Tinteren

Head Trial and Data Center
  • Trial and Data Center
Harm van Tinteren
Harm van Tinteren
--
Phone 31 65 01 73 064

--

  • Pediatric renal tumor epidemiology

    • jan. 2023
    • Jaime, Libes, et al
    • Pediatric Blood and Cancer
  • Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancer

    • nov. 2022
    • Sonja B., Vliek, et al
    • European Journal of Cancer
  • Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature

    • jul. 2022
    • M., Opdam, et al
    • Breast Cancer Research and Treatment
  • International Comparisons of Clinical Demographics and Outcomes in the International Society of Pediatric Oncology Wilms Tumor 2001 Trial and Study

    • mei 2022
    • Joaquim Caetano, De Aguirre-Neto, et al
    • JCO Global Oncology
  • Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer

    • mei 2022
    • Willem J.A., Witlox, et al
    • Radiotherapy and Oncology
View all publications